Dr. Scott Gottleib, a former deputy commissioner at the FDA, reviewed Chasing Medical Miracles favorably in today’s Wall Street Journal…

“Mr. O’Meara is adept at portraying clinical trials and in discussing ethical concerns — about CROs possibly skewing results to favor the interests of the drug companies that hire them, and about the financial incentive for clinical-trial applicants to lie about their medical history. “